The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.

A new fund is providing up to $5,000 to Boston families who have an immediate family member who died from an opioid overdose.

Multiple states have reached a tentative new agreement with the Sackler family, who made billions of dollars marketing OxyContin, the drug that set off the U.S. opioid crisis. New York State Attorney ...

Mr. Agather writes Jan. 23, “I hate to see stupidity rewarded.” As for me, I hate to see false and misleading claims rewarded. Hurricane-force winds and extraordinarily dry conditions were the prime ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

Launched in 2014 by then— Purdue President Mitch Daniels and continued in 2023 by President Mung Chiang, the Presidential Lecture Series exposes Purdue students and the broader community to inspiring ...

Purdue’s Agricultural Economics Department covers a wide array of issues from development, trade, macroeconomics policy implications, agribusiness, production and consumption all the way to ...

Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 1,01,355.31 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...